Trial intelligence / Profile preview

Ferriprox in pediatric iron overload

NCT00529152Phase 3Completed

Sponsor
ApoPharma Inc.
Start
Aug 2007
Primary completion
Jul 2008
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of deferiprone in iron overload, sponsored by ApoPharma Inc.. Started Aug 2007; status: completed.

02

Drugs

deferiprone
03

Conditions

iron overload

Beyond the preview

Go deeper on NCT00529152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00529152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call